- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PCI-32765 (Treatment B)
Total 647 results
-
Novartis VaccinesCompletedMeningococcal DiseaseUnited States, Australia, Canada
-
AstraZenecaCompleted
-
Janssen Research & Development, LLCCompleted
-
AstraZenecaParexelNot yet recruiting
-
Hui BuUnknownCryptococcal Meningitis
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnAmyloidosis | Immunoglobulin Light Chain Deposition
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Henry Ford Health SystemM.D. Anderson Cancer CenterCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Rabin Medical CenterCompletedNosocomial Infections | Community-associated Infections | Health-care Acquired InfectionsIsrael
-
University of PittsburghNational Institute on Disability, Independent Living, and Rehabilitation...CompletedCerebral Palsy | Amyotrophic Lateral Sclerosis | Traumatic Brain Injury | Speech Disorders | Brain Stem StrokeUnited States
-
PfizerArvinas Estrogen Receptor, Inc.Recruiting
-
University of Illinois at Urbana-ChampaignNational Honey BoardCompletedGastrointestinal Dysfunction | Physiological Stress | Cognition - OtherUnited States
-
Smt. Kashibai Navale Medical College and General...CompletedType 2 Diabetes | Vitamin B12 Deficiency | HyperhomocysteinemiaIndia
-
University Hospital, BordeauxRecruitingMetastatic Renal Cell Carcinoma | Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC ScoreFrance
-
University of California, San FranciscoUniversity of California, Davis; Arkansas Children's Hospital Research InstituteCompletedAutistic DisorderUnited States
-
Alimentiv Inc.Takeda Development Center Americas, Inc.Active, not recruitingColitis, UlcerativeCanada, Italy, United Kingdom, Poland, Netherlands, Ukraine, Belarus, United States, Belgium, France
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
PCI Biotech ASTerminatedCholangiocarcinomaUnited States, Spain, Belgium, Germany, Italy, Denmark, Finland, France, Korea, Republic of, Norway, Poland, Sweden, Taiwan, Ukraine
-
Universidad de GranadaAsociación Española contra el CáncerRecruiting
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Dr. med. Mahir KarakasCompletedBiotin Ingestion | Interference With Routine Analyical TestsGermany
-
Mayo ClinicNational Institute on Aging (NIA)Active, not recruitingAlzheimer DiseaseUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLymphoma, Mantle-CellTaiwan, Thailand, Malaysia, India, Puerto Rico, Spain, Turkey, Czechia, Brazil, Greece, Poland, Sweden, Romania
-
AstraZenecaCompletedChronic Kidney DiseaseUnited States
-
Chong Kun Dang PharmaceuticalCompletedHypertension | DyslipidemiasKorea, Republic of
-
Meir Medical CenterTerminatedRecurrent Aphthous StomatitisIsrael
-
Oramed, Ltd.IntegriumCompletedType 1 DiabetesUnited States
-
University of California, San FranciscoNational Psoriasis FoundationActive, not recruitingPsoriasis | Psoriasis VulgarisUnited States
-
University of Sao Paulo General HospitalBioMérieuxCompletedHeart Failure | Respiratory Tract Infections | Pneumonia, BacterialBrazil
-
Janssen Research & Development, LLCCompletedHealthyNetherlands, Germany, Belgium
-
Institut Claudius RegaudAstraZenecaActive, not recruitingDiffuse Large B-cell LymphomaFrance
-
Abivax S.A.CompletedChronic Hepatitis BNew Zealand, Australia
-
IlDong Pharmaceutical Co LtdCompleted
-
Hoffmann-La RocheCompletedHealthy VolunteersUnited States
-
Janssen Cilag S.A.S.Completed
-
Texas Tech University Health Sciences CenterCompletedUreteral InjuryUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingMantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Lymphoplasmacytic... and other conditionsUnited States, Canada
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
University of KwaZuluCompletedChronic Non-specific Low Back PainNigeria
-
Prof. Dr. med. Dirk SchadendorfCompletedMalignant MelanomaGermany
-
Janssen Research & Development, LLCCompleted
-
King's College LondonUniversity College, LondonUnknown
-
Merck Sharp & Dohme LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Merck Sharp & Dohme LLCCompletedHuman Immunodeficiency Virus-1 (HIV-1)
-
Georgetown UniversityNational Cancer Institute (NCI)TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States